This is a StreetInsider.com Premium Only Page

GSK (GSK) –

Apr 24, 2024 06:46 AM Form 6-K GSK plc For: Apr 24

Apr 19, 2024 10:56 AM Form 6-K GSK plc For: Apr 19

Apr 17, 2024 10:53 AM Form 6-K GSK plc For: Apr 17

Apr 17, 2024 06:12 AM Form 6-K GSK plc For: Apr 17

Apr 17, 2024 06:08 AM Form 6-K GSK plc For: Apr 17

Apr 16, 2024 02:29 PM GSK (GSK) call put ratio 12 calls to 1 put with focus on April weekly (26) 41 calls

Apr 16, 2024 09:50 AM Form 6-K GSK plc For: Apr 16

Apr 16, 2024 06:21 AM Form 6-K GSK plc For: Apr 16

Apr 15, 2024 11:26 AM Form 6-K GSK plc For: Apr 15

Apr 8, 2024 08:26 AM ViiV Healthcare announces U.S. FDA approval of Dovato for adolescents living with HIV (GSK) (PFE)

Apr 8, 2024 08:23 AM ViiV Healthcare announces U.S. FDA approval of Dovato (dolutegravir/lamivudine) for adolescents living with HIV

Apr 8, 2024 12:45 AM GlaxoSmithKline (GSK:LN) (GSK) PT Raised to GBP17.25 at Barclays

Apr 4, 2024 07:47 AM Form 6-K/A GSK plc For: Apr 04

Apr 2, 2024 01:17 PM Form 6-K GSK plc For: Apr 02

Mar 26, 2024 09:53 AM WuXi Biologics Reports Solid 2023 Annual Results

Mar 26, 2024 07:46 AM Form 6-K GSK plc For: Mar 26

Mar 25, 2024 02:04 PM Form F-3ASR GSK plc

Mar 25, 2024 09:38 AM Form 6-K GSK plc For: Mar 25

Mar 22, 2024 12:48 PM Form 6-K GSK plc For: Mar 22

Mar 22, 2024 12:17 PM Form 6-K GSK plc For: Mar 22

Mar 19, 2024 11:50 AM GlaxoSmithKline (GSK:LN) (GSK) PT Raised to GBP20.40 at UBS

Mar 18, 2024 09:57 AM Form 6-K GSK plc For: Mar 18

Mar 16, 2024 08:00 AM Positive RUBY phase III data show potential for Jemperli (dostarlimab-gxly) combinations in more patients with primary advanced or recurrent endometrial cancer

Mar 13, 2024 01:15 PM Form 6-K GSK plc For: Mar 13

Mar 12, 2024 06:21 AM JPMorgan on GlaxoSmithKline (GSK:LN) (GSK): 'Dr. Sherbonou continues to see the ocular toxicity profile of Blenrep as challenging'

Mar 8, 2024 12:49 PM Form 6-K GSK plc For: Mar 08

Mar 7, 2024 12:00 PM GSK Doubles COiMMUNITY Grant Funding, Launches Patient Resources, as Adult Vaccination Rates Begin to Show Promising Rise

Mar 7, 2024 06:14 AM Form 6-K GSK plc For: Mar 07

Mar 6, 2024 12:05 PM ViiV Healthcare Announces Interim Data at CROI Indicating Superior Efficacy of Long-Acting Injectable HIV Treatment Cabenuva (Cabotegravir + Rilpivirine) Compared to Daily Oral Therapy in Individuals

Mar 6, 2024 11:12 AM Form 6-K GSK plc For: Mar 06

Mar 5, 2024 01:10 PM Form 6-K GSK plc For: Mar 05

Mar 5, 2024 12:30 PM Form IRANNOTICE GSK plc

Mar 5, 2024 12:16 PM Form 20-F GSK plc For: Dec 31

Mar 5, 2024 08:48 AM ViiV Healthcare and The American Academy of HIV Medicine Announce Fellowship to Improve HIV Prevention in Key Communities

Mar 5, 2024 06:11 AM Form 6-K GSK plc For: Mar 05

Mar 4, 2024 01:50 PM ViiV Healthcare presents phase I clinical trial findings of a cabotegravir long-acting injectable investigational formulation allowing at least four months between doses

Mar 4, 2024 04:30 AM Guggenheim Upgrades GlaxoSmithKline (GSK) to Buy, 'Vaccines, HIV, I&I, AND Oncology Set Up Improved 2024+ Growth'

Mar 4, 2024 02:29 AM Guggenheim Upgrades GlaxoSmithKline (GSK:LN) (GSK) to Buy

Mar 4, 2024 02:11 AM GlaxoSmithKline (GSK:LN) (GSK) PT Raised to GBP18.30 at Morgan Stanley

Mar 1, 2024 10:30 AM Form 6-K GSK plc For: Mar 01

Mar 1, 2024 09:56 AM Form 6-K GSK plc For: Mar 01

Feb 29, 2024 06:28 AM Form 6-K GSK plc For: Feb 29

Feb 29, 2024 06:28 AM Form 6-K GSK plc For: Feb 29

Feb 28, 2024 10:04 AM ViiV Healthcare to present data for its next generation of ultra long-acting treatments for HIV

Feb 26, 2024 10:39 AM Form 6-K GSK plc For: Feb 26

Feb 26, 2024 06:39 AM Form 6-K GSK plc For: Feb 26

Feb 22, 2024 10:46 AM Form 6-K GSK plc For: Feb 22

Feb 21, 2024 06:40 AM Form 6-K GSK plc For: Feb 21

Feb 20, 2024 06:51 AM Form 6-K GSK plc For: Feb 20

Feb 20, 2024 04:14 AM Deutsche Bank Reiterates Buy Rating on GlaxoSmithKline (GSK:LN) (GSK)